Biotech leader, leading lab leak theorist no longer in consideration for top infectious disease role
Steven Quay, a biopharmaceutical executive with no background in infectious diseases, is no longer being considered for ...
The gifts and payments that doctors receive from drugmakers increased inappropriate prescribing, likely leading to rising ...
In 2030, U.S. mortality and morbidity rates will suddenly jump. This will happen not because there is a new pandemic or a ...
With research on abortion access barriers, STAT Wunderkind Betsy Pleasants is defining a framework for using AI tools without ...
As the midterm elections draw near, the MAHA movement is nearly invisible on the campaign trail and struggling to find a ...
The federal government has released new quality ratings for Medicare Advantage insurers for 2027, with Humana emerging as the ...
The AHA is once again suing the Trump administration over its plan to revamp a federal drug discount program into one that ...
Basic studies led to clinical and translational advances that no one could have predicted,” Robert Gallo writes of his work ...
The Trump administration wants to make three big changes to the U.S. Census, including eliminating questions about race, ...
Theresa covers substance use and addiction and co-writes the Morning Rounds newsletter. You can reach Theresa on Signal at theresagaff.97. Get your daily dose of health and medicine every weekday with ...
The FDA flagged a potential safety signal after four patient deaths in a trial testing a schizophrenia drug, Argenx faces an unusual setback, and more pharma news.
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results